HER-2/neu Assessment in Breast Cancer by Immunohistochemistry and Fluorescence In Situ Hybridization: Comparison of Results and Correlation With Survival

被引：0
|
作者：
Sanjay Kakar
Nick Puangsuvan
Jane M. Stevens
Romualda Serenas
George Mangan
Shalini Sahai
Michael L. Mihalov
机构：
[1] University of Illinois at Chicago,Department of Pathology
来源：
Molecular Diagnosis | 2000年 / 5卷 / 3期
关键词：
prognosis; Herceptin;
D O I：
10.1007/BF03262077
中图分类号：
学科分类号：
摘要：
Background: HER-2/neu immunohistochemistry (IHC) and fluorescence insitu hybridization (FISH) results guide breast cancer therapy; however, few studies compared the results and no published studies have correlated them with patient outcome.
引用
收藏
页码：199 / 207
页数：8
相关论文
共 50 条
  • [31] Comparison of PathVysion and INFORM Fluorescence In Situ Hybridization Kits for Assessment of HER-2/neu Status in Breast Carcinoma
    Sanjay Kakar
    Nick Puangsuvan
    Jane M. Stevens
    Romualda Serenas
    George Mangan
    Shalini Sahai
    Michael L. Mihalov
    Molecular Diagnosis, 2000, 5 (3) : 193 - 197
  • [32] Comparison of PathVysion and INFORM fluorescence in situ hybridization kits for assessment of HER-2/neu status in breast carcinoma
    Kakar, S
    Puangsuvan, N
    Stevens, JM
    Serenas, R
    Mangan, G
    Sahai, S
    Mihalov, ML
    MOLECULAR DIAGNOSIS, 2000, 5 (03): : 193 - 197
  • [33] HER-2/neu overexpression:: immunohistochemistry (IHC) or fluorescence in-situ hybridization (FISH)?
    Bunis, JA
    Weaver, DL
    Wells, WA
    Cole, BF
    Memoli, V
    Cates, J
    Schwartz, G
    Muss, HB
    Kaufman, PA
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S142 - S142
  • [34] Strong correlation between results of fluorescent in situ hybridization and immunohistochemistry for the assessment of the ERBB2 (HER-2/neu) gene status in breast carcinoma
    Couturier, J
    Vincent-Salomon, A
    Nicolas, A
    Beuzeboc, P
    Mouret, E
    Zafrani, B
    Sastre-Garau, X
    MODERN PATHOLOGY, 2000, 13 (11) : 1238 - 1243
  • [35] Comparison of HER-2/neu oncogene amplification detected by fluorescence in situ hybridization in lobular and ductal breast cancer
    Rosenthal, SI
    Depowski, PL
    Sheehan, CE
    Ross, JS
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2002, 10 (01): : 40 - 46
  • [36] HER-2 analysis in tissue microarrays of archival human breast cancer - Comparison of immunohistochemistry and fluorescence in situ hybridization
    O'Grady, A
    Flahavan, CM
    Kay, EW
    Barrett, HL
    Leader, MB
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2003, 11 (02): : 177 - 182
  • [37] Comparison of fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC) for the evaluation of HER2/neu in breast cancer.
    Jacobs, TW
    Barnes, MJ
    Yaziji, H
    Gown, AM
    Schnitt, SJ
    LABORATORY INVESTIGATION, 1999, 79 (01) : 23A - 23A
  • [38] Detection of HER-2/neu gene amplification by fluorescence in situ hybridization in human breast cancer
    Coupier, I
    Llorca, FP
    Perissel, B
    Tchirkov, A
    Malet, P
    CYTOGENETICS AND CELL GENETICS, 1999, 85 (1-2): : 120 - 120
  • [39] Comparison of breast cancer HER-2 receptor testing with immunohistochemistry and in-situ-hybridization
    Shanmugalingam, A.
    Hitos, K.
    Pathmanathan, N.
    Edirimmane, S.
    Hughes, M. T.
    Ngui, N. K.
    BREAST, 2023, 68 : S29 - S29
  • [40] Assessment of HER-2/Neu status by immunohistochemistry and fluorescence in situ hybridization in mammary Paget disease and underlying carcinoma
    Anderson, JM
    Ariga, R
    Govil, H
    Bloom, KJ
    Francescatti, D
    Reddy, VB
    Gould, VE
    Gattuso, P
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2003, 11 (02) : 120 - 124
12345